Jaime Contreras, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 674 shares at $41.78 ($28K) on 2016-03-31, disclosed to the SEC on 2016-04-01.
Scheduled sale ($28k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.65 | 212 | $9K | 31.4% |
| 2 | $41.78 | 138 | $6K | 20.5% |
| 3 | $41.78 | 162 | $7K | 24.1% |
| 4 | $41.79 | 162 | $7K | 24.1% |
| Total | $41.74 avg | 674 | $28K | 100% |
| Filing → |
| ABT | SELL | 2019-04-24 | $134K | — | Filing → |
| ABT | SELL | 2019-03-04 | $1.9M | — | Filing → |
| ABT | SELL | 2019-02-01 | $12.4M | — | Filing → |